Brighton Jones’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-24,157
Closed -$29.7K – 1478
2026
Q2
$29.7K Buy
24,157
+13,133
+119% +$13.1K ﹤0.01% 1388
2026
Q1
$7.74K Buy
+11,024
New +$10.3K ﹤0.01% 1197

Other funds holding MXCT

Brighton Jones's MXCT Position: Q3 2026 in Review

Brighton Jones sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 24,157 shares — an estimated $29.7K sold.

Brighton Jones first reported a position in MXCT in Q1 2026 and held it in 2 quarters. The position peaked at $29.7K in Q2 2026. 97 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Brighton Jones reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 24,157 MaxCyte shares in Q3 2026, an estimated $29.7K.
  • Brighton Jones first reported a position in MaxCyte in Q1 2026 and held it in 2 quarters.
  • Brighton Jones's MaxCyte position peaked at $29.7K in Q2 2026.
  • 97 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.